Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed

Teruhito Takakuwa1, Yusuke Okayama2, Hirohisa Nakamae2

  • 1Department of Hematology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. t_takakuwa@med.osaka-cu.ac.jp.

Annals of Hematology
|February 26, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos